You just read:

ReCor Medical Announces 6 Month On-Medication Results from RADIANCE-HTN SOLO Clinical Trial and the First Randomization in the RADIANCE-II Pivotal Study

News provided by

ReCor Medical, Inc.

Mar 17, 2019, 10:30 ET